Metabolism & Endocrinology ELISAs & RIAs

Request Information

---

Related Resources: Analyte Quarterly

---

Request Poster
Exercise and Immune Signals   Request poster while supplies last! Request Your Copy

With the rise in incidence of atherosclerosis, coronary heart disease, type 2 diabetes and kidney disease, metabolic syndrome research is a focus of the biomedical community. That’s why researchers rely on Merck’s 25 years of experience in developing ELISAs, RIAs and other single protein assays for metabolic syndrome biomarkers. Each assay undergoes stringent validation with high lot-to-lot consistency, inter- and intra-assay precision. Standards are validated to match reference lots—in many cases, World Health Organization standards are available and used for final quality control testing.

Advance Your Metabolic Syndrome Research and Endocrinology with ELISAs and RIA

Precisely quantify biomarkers for metabolic syndrome research and endocrinology in sera and lysates using the trusted ELISA and RIA techniques. Our ELISAs and other single protein assays detect analytes such as:

• GLP-1 active
• GLP-1 total 
• Rat/Mouse Insulin
• Human Leptin 
• Human Adiponectin
• Human GIP

New assays, including those detecting metabolic syndrome and endocrinology biomarkers, will be introduced into our portfolio each quarter— sign up here to download a pdf or receive a hard copy of this quarter's update.

---